{"product_id":"dr-aaron-waxman-pulmonary-arterial-hypertension-and-heart-failure-expert-biography-0","title":"Dr. Aaron Waxman. Pulmonary Arterial Hypertension and Heart Failure expert. Biography. 0","description":"\u003ch1\u003eUnderstanding Pulmonary Arterial Hypertension and Heart Failure with Preserved Ejection Fraction\u003c\/h1\u003e\n\n\u003ch3\u003eJump To Section\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#what-is-pulmonary-arterial-hypertension\"\u003eWhat is Pulmonary Arterial Hypertension?\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#recognizing-symptoms-of-pah\"\u003eRecognizing Symptoms of PAH\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#common-causes-of-pulmonary-hypertension\"\u003eCommon Causes of Pulmonary Hypertension\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#the-challenge-of-hfpef-diagnosis\"\u003eThe Challenge of HFpEF Diagnosis\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#research-focus-on-vascular-remodeling\"\u003eResearch Focus on Vascular Remodeling\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#expert-background-and-credentials\"\u003eExpert Background and Credentials\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#full-transcript\"\u003eFull Transcript\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"what-is-pulmonary-arterial-hypertension\"\u003eWhat is Pulmonary Arterial Hypertension?\u003c\/h2\u003e\n\u003cp\u003eDr. Aaron Waxman, MD, defines pulmonary arterial hypertension (PAH) as a specific type of high blood pressure. This condition affects the arteries in the lungs and the right side of the heart. PAH involves the narrowing and blocking of small lung arteries. This increases pressure and forces the heart to work harder.\u003c\/p\u003e\n\u003cp\u003eThe increased workload can lead to right heart failure over time. Dr. Aaron Waxman, MD, emphasizes that PAH is a serious, progressive disease. It requires expert diagnosis and specialized management strategies.\u003c\/p\u003e\n\n\u003ch2 id=\"recognizing-symptoms-of-pah\"\u003eRecognizing Symptoms of PAH\u003c\/h2\u003e\n\u003cp\u003eShortness of breath is the hallmark symptom of pulmonary arterial hypertension. Dr. Aaron Waxman, MD, notes this symptom often occurs during routine physical activity. Patients may also experience fatigue, chest pain, or a racing heartbeat.\u003c\/p\u003e\n\u003cp\u003eDizziness and fainting spells are other critical warning signs. Swelling in the ankles, legs, or abdomen can indicate advancing heart failure. Dr. Waxman stresses that these symptoms are frequently mistaken for more common conditions like asthma.\u003c\/p\u003e\n\n\u003ch2 id=\"common-causes-of-pulmonary-hypertension\"\u003eCommon Causes of Pulmonary Hypertension\u003c\/h2\u003e\n\u003cp\u003ePulmonary hypertension has multiple potential causes. Dr. Aaron Waxman, MD, explains that idiopathic PAH has no known cause. Heritable genetic mutations account for a portion of cases. Connective tissue diseases like scleroderma are a significant associated condition.\u003c\/p\u003e\n\u003cp\u003eCongenital heart disease and chronic liver disease can also lead to PAH. Dr. Waxman's expertise includes thromboembolic disease, another major cause. This refers to chronic blood clots in the lungs that elevate pressure.\u003c\/p\u003e\n\n\u003ch2 id=\"the-challenge-of-hfpef-diagnosis\"\u003eThe Challenge of HFpEF Diagnosis\u003c\/h2\u003e\n\u003cp\u003eHeart failure with preserved ejection fraction (HFpEF) is a frequent source of diagnostic confusion. Dr. Aaron Waxman, MD, highlights that HFpEF is a common mimic of pulmonary hypertension. Patients present with identical symptoms like severe shortness of breath.\u003c\/p\u003e\n\u003cp\u003eThis condition is notoriously difficult to diagnose accurately. It requires a comprehensive evaluation to distinguish it from PAH. Dr. Waxman's work at Brigham and Women's Hospital focuses on this precise differential diagnosis.\u003c\/p\u003e\n\n\u003ch2 id=\"research-focus-on-vascular-remodeling\"\u003eResearch Focus on Vascular Remodeling\u003c\/h2\u003e\n\u003cp\u003eDr. Aaron Waxman, MD, directs his research toward understanding pulmonary vascular remodeling. His work investigates the inflammatory mechanisms that drive disease progression. This process involves changes in the structure of blood vessel walls.\u003c\/p\u003e\n\u003cp\u003eThese changes lead to increased resistance and pressure in the lung circulation. Dr. Waxman's research, including his time at the Howard Hughes Medical Institute, aims to uncover new therapeutic targets. This work is crucial for developing better treatments for right heart failure.\u003c\/p\u003e\n\n\u003ch2 id=\"expert-background-and-credentials\"\u003eExpert Background and Credentials\u003c\/h2\u003e\n\u003cp\u003eDr. Aaron Waxman, MD, is a highly credentialed specialist in pulmonary vascular disease. He is an Associate Professor of Medicine at Harvard Medical School. Dr. Waxman serves as the Executive Director of the Center for Pulmonary Heart Diseases.\u003c\/p\u003e\n\u003cp\u003eHe also directs the Pulmonary Vascular Disease Program at Brigham and Women's Hospital. Dr. Waxman earned his MD from Yale University School of Medicine. He completed his residency and pulmonary fellowship at Yale New Haven Hospital.\u003c\/p\u003e\n\u003cp\u003eDr. Anton Titov, MD, interviewed Dr. Waxman to share this critical expertise. Dr. Waxman's extensive publication record includes over 150 peer-reviewed articles. His presentations at international conferences have shaped the field of cardiopulmonary medicine.\u003c\/p\u003e\n\u003ch2 id=\"full-transcript\"\u003eFull Transcript\u003c\/h2\u003e\n\u003cp\u003eDr. Aaron Waxman is one of the world’s top experts in shortness of breath differential diagnosis. Often shortness of breath is caused by pulmonary hypertension, or HFpEF, heart failure with preserved ejection fraction. It is a condition that is frequently misdiagnosed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Hello from Boston! We are with Dr. Aaron Waxman, MD. He is Associate Professor of Medicine at Harvard Medical School. He is Executive Director of the Center for Pulmonary Heart Diseases and Director of the Pulmonary Vascular Disease Program at Brigham and Women's Hospital in Boston.\u003c\/p\u003e\n\u003cp\u003eDr. Waxman obtained his MD from Yale University School of Medicine and his PhD from Albany Medical College in New York. He did residency training in medicine at the Yale New Haven Hospital and a fellowship in pulmonary and critical care at the Yale New Haven Hospital. Dr. Aaron Waxman, MD, did research at the Howard Hughes Medical Institute.\u003c\/p\u003e\n\u003cp\u003eDr. Waxman's clinical and research interests include pulmonary arterial hypertension, right heart failure, thromboembolic disease, and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure.\u003c\/p\u003e\n\u003cp\u003eDr. Aaron Waxman, MD, has authored and co-authored over 150 peer-reviewed publications in international medical journals and presented numerous talks at international conferences on heart and lung disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e Dr. Waxman, thank you and welcome!\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Aaron Waxman, MD:\u003c\/strong\u003e Thank you!\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Anton Titov, MD:\u003c\/strong\u003e What is pulmonary arterial hypertension? How to recognize its symptoms? What are some of its causes?\u003c\/p\u003e","brand":"Diagnostic Detectives Network","offers":[{"title":"Default Title","offer_id":41852121743516,"sku":"","price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/es\/products\/dr-aaron-waxman-pulmonary-arterial-hypertension-and-heart-failure-expert-biography-0","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}